Message from the President

Message from the President

Improving Quality of Life through
Solutions Spanning All Stages of
the Care Cycle

Masaki Taneda

Improving Quality of Life through Solutions Spanning All Stages of the Care Cycle

Masaki Taneda

Teijin Pharma walks alongside every one of our patients. Within our core priority fields of bone, joint, rehabilitation, neurology, respiratory, cardiovascular and metabolic, we are responding to social change and taking steps to realize healthcare for the society of the future. Our goal is a society where people can live the lifestyle of their choice, regardless of their age. Our corporate philosophy, enhancing the quality of life, is our starting point for everything. By providing total healthcare solutions, we are evolving into a company that will support future society.

In 2025, Japan’s baby boomer generation will begin to turn 75. We predict this milestone will trigger rapid change in the medical treatment and nursing care of the elderly. As one of the world’s few super-aged societies, Japan is where we, Teijin Pharma, are concentrating our efforts to develop a unique, new perspective on total healthcare solutions. We believe in supporting all stages of the care cycle, from disease prevention and healthy living, to treatment, rehabilitation, nursing care and lifestyle assistance, evolving to address the issues faced by patients, families and communities who are in need of more support.

Right now, our focus is on reinforcing Teijin Pharma’s globally active drug development platform. As well as maintaining a network of administrative and sales locations established in communities across Japan, we are advancing new platforms including customer centers, home visit nursing stations and our VitalLink patient information sharing system. While we are attuned to the issues faced by society at large, we endeavor to provide flexible and sensitive care that is optimized to patients as individuals, going beyond existing pharmaceutical, home healthcare and ICT frameworks. Further, we are prioritizing startup co-creation and diversity, particularly in the fields of rare and intractable diseases, to evolve conventional approaches. Every member of Teijin Pharma is an evolutionary leader, and our passion for breaking new ground is at the heart of every move we make.

Masaki Taneda
President, Teijin Pharma Limited

Masaki Taneda

In 2025, Japan’s baby boomer generation will begin to turn 75. We predict this milestone will trigger rapid change in the medical treatment and nursing care of the elderly. As one of the world’s few super-aged societies, Japan is where we, Teijin Pharma, are concentrating our efforts to develop a unique, new perspective on total healthcare solutions. We believe in supporting all stages of the care cycle, from disease prevention and healthy living, to treatment, rehabilitation, nursing care and lifestyle assistance, evolving to address the issues faced by patients, families and communities who are in need of more support.

Right now, our focus is on reinforcing Teijin Pharma’s globally active drug development platform. As well as maintaining a network of administrative and sales locations established in communities across Japan, we are advancing new platforms including customer centers, home visit nursing stations and our VitalLink patient information sharing system. While we are attuned to the issues faced by society at large, we endeavor to provide flexible and sensitive care that is optimized to patients as individuals, going beyond existing pharmaceutical, home healthcare and ICT frameworks. Further, we are prioritizing startup co-creation and diversity, particularly in the fields of rare and intractable diseases, to evolve conventional approaches. Every member of Teijin Pharma is an evolutionary leader, and our passion for breaking new ground is at the heart of every move we make.

Masaki Taneda
President, Teijin Pharma Limited

Masaki Taneda

Related Links

Our Business

Page Top